AFATINIB for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 824 adverse event reports in the FDA FAERS database where AFATINIB was used for Lung neoplasm malignant.
Most Reported Side Effects for AFATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 2,001 | 32.9% | 351 | 984 |
| Malignant neoplasm progression | 1,622 | 26.7% | 445 | 283 |
| Rash | 808 | 13.3% | 131 | 315 |
| Stomatitis | 468 | 7.7% | 77 | 234 |
| Death | 443 | 7.3% | 443 | 63 |
| Nausea | 430 | 7.1% | 69 | 280 |
| Decreased appetite | 412 | 6.8% | 85 | 255 |
| Vomiting | 381 | 6.3% | 67 | 271 |
| Paronychia | 344 | 5.7% | 62 | 133 |
| Dehydration | 323 | 5.3% | 56 | 276 |
| Fatigue | 256 | 4.2% | 52 | 128 |
| Metastases to central nervous system | 248 | 4.1% | 72 | 58 |
| Asthenia | 221 | 3.6% | 46 | 151 |
| Off label use | 204 | 3.4% | 64 | 37 |
| Drug ineffective | 203 | 3.3% | 31 | 47 |
Other Indications for AFATINIB
Non-small cell lung cancer (2,010)
Product used for unknown indication (916)
Lung adenocarcinoma (876)
Egfr gene mutation (780)
Non-small cell lung cancer metastatic (285)
Lung adenocarcinoma stage iv (146)
Adenocarcinoma (144)
Squamous cell carcinoma of head and neck (76)
Non-small cell lung cancer stage iv (74)
Lung cancer metastatic (68)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)